RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Huaren Pharmaceutical Co Stock

Huaren Pharmaceutical Co Net Income 2025

Huaren Pharmaceutical Co Net Income

-1.37 B CNY

Ticker

300110.SZ

ISIN

CNE100000SW1

In 2025, Huaren Pharmaceutical Co's profit amounted to -1.37 B CNY, a -827.67% increase from the 188.06 M CNY profit recorded in the previous year.

The Huaren Pharmaceutical Co Net Income history

YEARNET INCOME (undefined CNY)
2024-1,368.48
2023188.06
2022180.82
2021130.4
202094.6
201942.1
201838.8
201737.5
201623.9
201522.9
201456.2
2013121.5
201296.6
201187.6
201076.3
200960.8
200846.4
200734.1

Huaren Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Huaren Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Huaren Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Huaren Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Huaren Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Huaren Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Huaren Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Huaren Pharmaceutical Co’s growth potential.

Huaren Pharmaceutical Co Revenue, EBIT and net profit per share

DateHuaren Pharmaceutical Co RevenueHuaren Pharmaceutical Co EBITHuaren Pharmaceutical Co Net Income
20241.35 B undefined-1.21 B undefined-1.37 B undefined
20231.64 B undefined286.11 M undefined188.06 M undefined
20221.62 B undefined251.97 M undefined180.82 M undefined
20211.56 B undefined213.47 M undefined130.4 M undefined
20201.62 B undefined121 M undefined94.6 M undefined
20191.46 B undefined97.6 M undefined42.1 M undefined
20181.38 B undefined74 M undefined38.8 M undefined
20171.31 B undefined100.5 M undefined37.5 M undefined
20161.25 B undefined82.6 M undefined23.9 M undefined
20151.11 B undefined80.2 M undefined22.9 M undefined
2014916.8 M undefined102.2 M undefined56.2 M undefined
2013867.2 M undefined164.3 M undefined121.5 M undefined
2012562 M undefined116.1 M undefined96.6 M undefined
2011405.3 M undefined89.3 M undefined87.6 M undefined
2010338.3 M undefined93.8 M undefined76.3 M undefined
2009288.5 M undefined87 M undefined60.8 M undefined
2008207.6 M undefined62.7 M undefined46.4 M undefined
2007161.1 M undefined45.7 M undefined34.1 M undefined

Huaren Pharmaceutical Co stock margins

The Huaren Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Huaren Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Huaren Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Huaren Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Huaren Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Huaren Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Huaren Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Huaren Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Huaren Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Huaren Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Huaren Pharmaceutical Co Margin History

Huaren Pharmaceutical Co Gross marginHuaren Pharmaceutical Co Profit marginHuaren Pharmaceutical Co EBIT marginHuaren Pharmaceutical Co Profit margin
202434.55 %-89.51 %-101.13 %
202342.53 %17.49 %11.49 %
202242.97 %15.56 %11.16 %
202148.7 %13.68 %8.35 %
202034.31 %7.49 %5.85 %
201956.11 %6.68 %2.88 %
201857.37 %5.35 %2.8 %
201752.91 %7.66 %2.86 %
201644.65 %6.61 %1.91 %
201544.39 %7.25 %2.07 %
201447.89 %11.15 %6.13 %
201353 %18.95 %14.01 %
201256.16 %20.66 %17.19 %
201155.24 %22.03 %21.61 %
201055.42 %27.73 %22.55 %
200956.29 %30.16 %21.07 %
200851.88 %30.2 %22.35 %
200744.63 %28.37 %21.17 %

Huaren Pharmaceutical Co Aktienanalyse

What does Huaren Pharmaceutical Co do?

Huaren Pharmaceutical Co. Ltd is a leading Chinese pharmaceutical company based in Beijing. It was founded in 1996 and has since experienced impressive growth. The company is listed on the Shanghai Stock Exchange under the ticker symbol SHA:600664. Huaren Pharmaceutical's history is characterized by a smart corporate strategy and a strong focus on customer needs. The company started as a small family business and built a strong presence in the Chinese market in the following years. This involved establishing innovative strategic partnerships with other companies in the industry. In 2010, the company went public, further accelerating its growth. The business model of Huaren Pharmaceutical is based on a wide product portfolio, including various products in the pharmaceutical, healthcare, and biotechnology industries. The company works closely with international experts and scientific institutes to ensure the highest quality and effectiveness of its products. It is active in research and development, production, and distribution of healthcare products and services, and has built strong industry expertise. The different divisions of Huaren Pharmaceutical include the production of antibiotics, vitamin complexes, painkillers, and vaccines. The company is also involved in diagnostic, hospital care, and medical device sectors. Another important division is the production of generics, which makes the company one of the major players in the Chinese generic drug market. Huaren Pharmaceutical takes pride in providing a comprehensive range of products for patients. Its key products include anti-cancer therapies, medications for nervous system disorders, cardiovascular diseases, and vascular diseases. The company has state-of-the-art research and development departments that ensure its products are always at the forefront of technology and meet customer needs. Due to its innovation capabilities, Huaren Pharmaceutical has won numerous awards and patents. The company aims to solidify its market leadership in China while expanding its presence in the Asian and global pharmaceutical markets. It also intends to focus on the biotechnology market and expand its research and development activities. With this strategic approach, Huaren Pharmaceutical aims to remain a significant player in the Chinese pharmaceutical industry and drive advancements and technologies in healthcare. Huaren Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Huaren Pharmaceutical Co's Profit Margins

The profit margins of Huaren Pharmaceutical Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Huaren Pharmaceutical Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Huaren Pharmaceutical Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Huaren Pharmaceutical Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Huaren Pharmaceutical Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Huaren Pharmaceutical Co stock

How much profit has Huaren Pharmaceutical Co made this year?

Huaren Pharmaceutical Co has made -1.37 B CNY this year.

How has the profit developed compared to last year?

The profit has increased by -827.67% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Huaren Pharmaceutical Co publish its earnings?

Huaren Pharmaceutical Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Huaren Pharmaceutical Co?

The profits of Huaren Pharmaceutical Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Huaren Pharmaceutical Co?

You can learn more about the earnings of Huaren Pharmaceutical Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Huaren Pharmaceutical Co pay?

Over the past 12 months, Huaren Pharmaceutical Co paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 0.64 %. For the coming 12 months, Huaren Pharmaceutical Co is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Huaren Pharmaceutical Co?

The current dividend yield of Huaren Pharmaceutical Co is 0.64 %.

When does Huaren Pharmaceutical Co pay dividends?

Huaren Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, August, August.

How secure is the dividend of Huaren Pharmaceutical Co?

Huaren Pharmaceutical Co paid dividends every year for the past 8 years.

What is the dividend of Huaren Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 0.64 %.

In which sector is Huaren Pharmaceutical Co located?

Huaren Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Huaren Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Huaren Pharmaceutical Co from 7/10/2024 amounting to 0.021 CNY, you needed to have the stock in your portfolio before the ex-date on 7/10/2024.

When did Huaren Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Huaren Pharmaceutical Co in the year 2024?

In the year 2024, Huaren Pharmaceutical Co distributed 0.021 CNY as dividends.

In which currency does Huaren Pharmaceutical Co pay out the dividend?

The dividends of Huaren Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Huaren Pharmaceutical Co

Our stock analysis for Huaren Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Huaren Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.